There is an undeniable stigma to most people's mind that if Leronlimab/LL is so good, LL should be FDA's holy grail already. I remember when I told my rich overseas friends to invest in CYDY a couple years ago. After their matrix investment teams looked into it, they always said if what I said LL is the gem, the FDA would jump on it. As for me, I can wait after being a hardcore CYDY believer even though I am not that smart for a $300K investment with a huge loss ONLY on paper now. Actually, it may be worse when my $300K adventure eventually turns into a $500K.